Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-25-000109
Filing Date
2025-01-15
Accepted
2025-01-15 15:41:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15720
2 JOINT FILING AGREEMENT ex991to13g14318inmb_011525.htm EX-99.1 9380
  Complete submission text file 0000921895-25-000109.txt   26761
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Subject) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90859 | Film No.: 25532815
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2420 AVE. DR. ALBIZU CAMPOS PMB 427 RINCON PR 00677
Business Address CARR 429, KM 4.1, BO BARRERO RINCON PR 00677 786-396-1281
Praetorian PR LLC (Filed by) CIK: 0001949877 (see all company filings)

EIN.: 660983992 | State of Incorp.: PR | Fiscal Year End: 1231
Type: SCHEDULE 13G